According to the 2013 State-of-Scrum Report, Agile/Scrum is being practiced in 33% of highly regulated industries like finance, healthcare, insurance and aerospace. This paper by …
Over the last ten years, the way that the pharmaceutical industry is expected to deliver new drug products to market has seen symbolic change. This …
As digital technology plays an increasingly important part in our everyday lives, it comes as no surprise that it has a huge potential to address …
Clinical trials are the experimental foundation on which modern medicine is built. Human medicines cannot be sold without permission from a licensing authority, and permission …
Mobile health (mHealth) may be the buzzword of today, but unlike many other buzzwords, this one will not be just another flash in the pan. …
Pyoderma gangrenosum (PG) is a rare and serious skin disease in which a painful nodule breaks down to form progressive enlarging ulcers, and leads to …
The availability of generic medication is an important issue in the ASEAN region. The regulatory requirements of various countries of the world vary from each …
The clinical monitoring cost is one of the major costs and accounts for one-third of the overall cost of clinical trial management. As the complexities …
The year 2015 marks the 10th anniversary of the release of two ICH Harmonised Tripartite Guidelines that have governed the cardiac safety regulatory landscape, more …
In recent years, numerous pharmaceutical and biotechnology companies have undertaken development programmes intended to assess the efficacy of various pro-cognitive drugs on a wide variety …
Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.
